Exploring the Genetic Link Between Stress and Type 2 Diabetes

 

Type 2 diabetes is frequently brought on by inflammation and elevated blood sugar, which destroys the pancreatic cells that make insulin. Genetics is a major influence in predicting an individual's vulnerability to the condition, even though lifestyle variables including poor food and lack of exercise are well-known contributions. The ability of cells to withstand molecular stress is compromised by specific DNA mutations, which raises the risk of diabetes. This discovery provides new insights into potential treatments aimed at preventing type 2 diabetes.

Type 2 diabetics experience stress that can result in cell dysfunction or death because their pancreatic beta cells, which produce insulin, are unable to keep up with the body's increasing insulin needs. These cells are subject to two main stressors: endoplasmic reticulum (ER) stress, which occurs when the overproduction of insulin overwhelms cellular machinery, and cytokine stress, which occurs when inflammatory signals—which are frequently associated with obesity and metabolic diseases—damage the cells even more, making it more difficult to regulate blood sugar.

Investigating the Genetic Response to Stress

The study investigated the genetic responses of human pancreatic cells to cytokine and ER stress. The researchers created similar stress conditions in healthy islet cells through chemical exposure, and then tracked alterations in the RNA levels and DNA architecture of the cells. According to their research, stress altered the expression of more than 5,000 genes. The majority of these genes were involved in protein synthesis, which is essential for the cells that produce insulin. Fascinatingly, the researchers found that distinct gene sets showed diverse responses to cytokine and ER stress, suggesting two different genetic pathways that are triggered by different kinds of cell stress.

They also discovered that stress changed specific DNA regulatory regions that regulate islet cell gene expression. Genetic variations linked to an increased risk of type 2 diabetes were present in several of these locations. This implies that individuals with particular genetic variations might have less stress-tolerant islet cells, which increases their risk of developing diabetes in situations involving sustained metabolic load.

MAP3K5's Function in Cellular Stress

As MAP3K5 was linked in both ER and cytokine stress responses, it became clear from the analysis that this gene was particularly significant. Pancreatic beta cells' ability to regulate cell death is influenced by MAP3K5. The researchers discovered that while inhibiting the gene's activity helped shield the cells, high levels of MAP3K5 increased the risk of beta cell mortality in response to stress.

The way diabetes is treated will be significantly affected by these results. Clinical trials are presently testing Selonsertib, a medication that targets MAP3K5, to lower the risk of serious complications connected to diabetes. According to recent studies, this medication may also be used to prevent diabetes by shielding islet cells from harm brought on by stress.

In conclusion, this study highlights how genetic variations, like those affecting the MAP3K5 gene, can influence the body’s ability to handle cellular stress, paving the way for personalized treatments for type 2 diabetes. While lifestyle changes remain important, targeting stress-related genes offers promising new approaches for preventing and managing the disease, addressing both genetic and environmental factors.

REFERENCES

1. Eishani K. Sokolowski, Romy Kursawe, Vijay Selvam, Redwan M. Bhuiyan, Asa Thibodeau, Chi Zhao, Cassandra N. Spracklen, Duygu Ucar, Michael L. Stitzel. Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights. Cell Metabolism, 2024; DOI: 10.1016/j.cmet.2024.09.006

 

IMAGE SOURCE

https://www.fitterfly.com/blog/type-1-and-type-2-diabetes-causes-symptoms-and-solutions/